Profit Margin (Quarterly) Chart

View Profit Margin (Quarterly) for ZTS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Profit Margin (Quarterly) Chart
Start Trial

Historical Profit Margin (Quarterly) Data

View and export this data back to 2011. Start Trial.
Date Value
June 30, 2026 28.00%
March 31, 2026 26.57%
December 31, 2025 25.26%
September 30, 2025 30.04%
June 30, 2025 29.35%
March 31, 2025 27.39%
December 31, 2024 25.08%
September 30, 2024 28.98%
June 30, 2024 26.43%
March 31, 2024 27.35%
December 31, 2023 23.63%
September 30, 2023 27.71%
June 30, 2023 30.73%
March 31, 2023 27.55%
December 31, 2022 22.55%
September 30, 2022 26.37%
June 30, 2022 25.78%
March 31, 2022 29.91%
December 31, 2021 21.00%
September 30, 2021 27.74%
June 30, 2021 26.23%
March 31, 2021 29.82%
December 31, 2020 19.81%
September 30, 2020 26.82%
June 30, 2020 24.29%
Date Value
March 31, 2020 27.58%
December 31, 2019 22.94%
September 30, 2019 27.34%
June 30, 2019 23.98%
March 31, 2019 21.44%
December 31, 2018 22.06%
September 30, 2018 23.45%
June 30, 2018 27.00%
March 31, 2018 25.62%
December 31, 2017 5.48%
September 30, 2017 21.97%
June 30, 2017 19.46%
March 31, 2017 19.42%
December 31, 2016 12.06%
September 30, 2016 19.10%
June 30, 2016 18.54%
March 31, 2016 17.56%
December 31, 2015 1.57%
September 30, 2015 15.65%
June 30, 2015 -3.06%
March 31, 2015 14.97%
December 31, 2014 9.55%
September 30, 2014 13.80%
June 30, 2014 12.00%
March 31, 2014 14.13%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Elanco Animal Health, Inc. 3.95%
Merck & Co., Inc. -8.06%
Phibro Animal Health Corp. 5.47%
Pfizer Inc. -1.64%
Boston Scientific Corp. 16.63%